363 related articles for article (PubMed ID: 16040412)
1. Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic--recognized and unrecognized infections.
Löwhagen GB; Berntsson M; Bonde E; Tunbäck P; Krantz I
Acta Derm Venereol; 2005; 85(3):248-52. PubMed ID: 16040412
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
Slomka MJ
Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
Ross SE; Carter B; Lambert S
Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
[TBL] [Abstract][Full Text] [Related]
5. Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management.
O'Farrell N; Morison L; Moodley P; Pillay K; Vanmali T; Quigley M; Sturm AW
Sex Transm Dis; 2008 Jun; 35(6):545-9. PubMed ID: 18356769
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre.
Bassett I; Donovan B; Bodsworth NJ; Field PR; Ho DW; Jeansson S; Cunningham AL
Med J Aust; 1994 Jun; 160(11):697-700. PubMed ID: 8202004
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics.
Gottlieb SL; Douglas JM; Schmid DS; Bolan G; Iatesta M; Malotte CK; Zenilman J; Foster M; Barón AE; Steiner JF; Peterman TA; Kamb ML;
J Infect Dis; 2002 Nov; 186(10):1381-9. PubMed ID: 12404152
[TBL] [Abstract][Full Text] [Related]
9. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study.
Janier M; Scieux C; Méouchi R; Tournoux C; Porcher R; Maillard A; Fouéré S; Taquin Y; Lassau F; Morel P
Int J STD AIDS; 2006 Jan; 17(1):44-9. PubMed ID: 16409679
[TBL] [Abstract][Full Text] [Related]
10. The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2.
Miyai T; Turner KR; Kent CK; Klausner J
Sex Transm Dis; 2004 Sep; 31(9):517-21. PubMed ID: 15480111
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris.
Janier M; Lassau F; Bloch J; Spindler E; Morel P; Gérard P; Aufrère A
Int J STD AIDS; 1999 Aug; 10(8):522-6. PubMed ID: 10471101
[TBL] [Abstract][Full Text] [Related]
12. Use of type-specific HSV serology in the management of a 37-year-old woman diagnosed with primary genital herpes.
Wilkinson D; Barton S
Herpes; 2001 Mar; 8(1):4-7. PubMed ID: 11867009
[TBL] [Abstract][Full Text] [Related]
13. Genital shedding of herpes simplex virus among men.
Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.
Lafferty WE; Downey L; Celum C; Wald A
J Infect Dis; 2000 Apr; 181(4):1454-7. PubMed ID: 10762576
[TBL] [Abstract][Full Text] [Related]
15. Current diagnostic techniques in genital herpes: their role in controlling the epidemic.
Slomka MJ
Clin Lab; 2000; 46(11-12):591-607. PubMed ID: 11109508
[TBL] [Abstract][Full Text] [Related]
16. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
17. [Herpes simplex virus type 1 and 2 in Switzerland].
Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
[TBL] [Abstract][Full Text] [Related]
18. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
Wald A; Ashley-Morrow R
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
[TBL] [Abstract][Full Text] [Related]
19. Herpes virus type 2 infection and genital symptoms in primary care patients.
Fleming DT; Leone P; Esposito D; Heitman CK; Justus S; Chin S; Fife KH
Sex Transm Dis; 2006 Jul; 33(7):416-21. PubMed ID: 16601657
[TBL] [Abstract][Full Text] [Related]
20. HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae.
Richards J; Scholes D; Caka S; Drolette L; Magaret AM; Yarbro P; Lafferty W; Crosby R; Diclemente R; Wald A
Sex Transm Dis; 2007 Sep; 34(9):718-25. PubMed ID: 17471113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
